Citigroup Downgrades MedAssets To Hold, PT To $20

February 25, 2011 7:25 AM | 7 seconds read | Make a Comment

Citigroup has downgraded MedAssets

MDAS

from Buy to Hold and has lowered the price target from $26 to $20.

Posted In: Downgrades Price Target Analyst Ratings Citigroup Health Care Health Care Technology medassets

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.